Over the years, the company has significantly grown its portfolio of products across mass and specialty therapies. Today, our portfolio has hundreds of products covering the whole spectrum of disease areas spanning gastroenterology, oncology, pain management, cardiovascular, dermatology, urology, nephrology, rheumatology and diabetes. Some of our brands are listed in “Top-500 of the Indian Pharma Market” and many others hold leadership positions in their respective categories.
As a company we have progressively transitioned from being a maker of molecules to a provider of medicines. Along the way we developed a deeper empathy for the needs of patients and their caregivers. This has impelled UCAILI as an organization to go beyond medicines and leverage our capabilities to meet some of these unmet patient needs. Our Purple Health initiative in India aims at taking patient care beyond the pill focusing our efforts in four areas:
Company works profile..........
Service offering.
Content.................
Content for this section................
Content for this section..................
Content for this section......................
Some Content for this section....................
Some content here.................